The bacillary response to chemotherapy in preclinical animal models used to evaluate TB drugs
| dc.contributor.author | Hoff, Donald R., author | |
| dc.contributor.author | Lenaerts, Anne J., advisor | |
| dc.contributor.author | Basaraba, Randall Joseph, 1958-, advisor | |
| dc.contributor.author | Olea-Popelka, Francisco Javier, 1974-, committee member | |
| dc.date.accessioned | 2007-01-03T04:41:04Z | |
| dc.date.available | 2007-01-03T04:41:04Z | |
| dc.date.issued | 2010 | |
| dc.description | Department Head: Edward Arthur Hoover. | |
| dc.description.abstract | Current drug treatment for tuberculosis (TB) consists of 6 to 9 months of daily multidrug therapy. The long duration of chemotherapy contributes to a high rate of treatment failure as patients fail to adhere to the prescribed regimen. The length of treatment is thought to be necessary to eradicate a small proportion of Mycobacterium tuberculosis bacilli that persist despite effective drug treatment. Developing drugs that target tubercle bacilli in this drug-refractory state must be found in order to shorten standard therapy. However, specific details on the nature of M. tuberculosis persistence are still lacking. Further hindering the drug discovery process is our incomplete knowledge of the how M. tuberculosis infects different animal models used to evaluate preclinical drug candidates. Pulmonary TB infection manifests and develops very differently between species routinely used to test these compounds and with respect to human infection. The main goal of this thesis is to facilitate the development of new, highly effective drugs for TB treatment by improving our understanding of M. tuberculosis persistence and of the animal models used to test experimental compounds in preclinical trials. | |
| dc.format.medium | masters theses | |
| dc.identifier | 2010_Spring_Hoff_Donald.pdf | |
| dc.identifier | ETDF2010100001MIPA | |
| dc.identifier.uri | http://hdl.handle.net/10217/38378 | |
| dc.language | English | |
| dc.language.iso | eng | |
| dc.publisher | Colorado State University. Libraries | |
| dc.relation.ispartof | 2000-2019 | |
| dc.rights | Copyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see https://libguides.colostate.edu/copyright. | |
| dc.title | The bacillary response to chemotherapy in preclinical animal models used to evaluate TB drugs | |
| dc.type | Text | |
| dcterms.rights.dpla | This Item is protected by copyright and/or related rights (https://rightsstatements.org/vocab/InC/1.0/). You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). | |
| thesis.degree.discipline | Microbiology, Immunology, and Pathology | |
| thesis.degree.grantor | Colorado State University | |
| thesis.degree.level | Masters | |
| thesis.degree.name | Master of Science (M.S.) |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2010_Spring_Hoff_Donald.pdf
- Size:
- 2.41 MB
- Format:
- Adobe Portable Document Format
- Description: